Keenova Therapeutics plc Reorganization Items
Keenova Therapeutics plc reported Reorganization Items of $0 for the 12-month period ending 2024-12-27, per its 10-K filed 2025-03-13.
Financial Statements › Notes › Reorganizations › Reorganization Items
us-gaap:ReorganizationItems · last filed 2026-04-15
- Keenova Therapeutics plc reorganization items for the quarter ending 2024-12-27 was $0.00.
- Keenova Therapeutics plc reorganization items for the quarter ending 2024-09-27 was $0.00, a 100.00% decline year-over-year.
- Keenova Therapeutics plc reorganization items for the quarter ending 2024-06-28 was $0.00, a 100.00% decline year-over-year.
- Keenova Therapeutics plc reorganization items for the quarter ending 2024-03-29 was $0.00, a 100.00% decline year-over-year.
- Keenova Therapeutics plc reorganization items for fiscal 2024 was $0.00.
- Keenova Therapeutics plc reorganization items for fiscal 2021 was -$428.20M.
- Keenova Therapeutics plc reorganization items for fiscal 2020 was -$61.40M.
- Keenova Therapeutics plc reorganization items for fiscal 2019 was $0.00.
| Period end | Reorganization Items 0 month | Reorganization Items 1 month | Reorganization Items 1 month as first filed | Reorganization Items 2 month | Reorganization Items 3 month | Reorganization Items 5 month | Reorganization Items 5 month as first filed | Reorganization Items 6 month | Reorganization Items 9 month | Reorganization Items 10 month | Reorganization Items 10 month as first filed | Reorganization Items 12 month | Reorganization Items 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-27 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $0.00 derived: sum of 2 quarters · filed 2025-03-13 | $0.00 derived: sum of 3 quarters · filed 2025-03-13 | $0.00 10-K · filed 2025-03-13 | |||||||||
| 2024-09-27 | $0.00 10-Q · filed 2024-11-05 | $0.00 derived: sum of 2 quarters · filed 2024-11-05 | $0.00 10-Q · filed 2024-11-05 | ||||||||||
| 2024-06-28 | $0.00 10-Q · filed 2024-08-06 | $0.00 10-Q · filed 2024-08-06 | |||||||||||
| 2024-03-29 | $0.00 10-Q · filed 2024-05-09 | ||||||||||||
| 2023-12-29 | $4.00M 10-K · filed 2026-04-15 | -$4.00M 10-K · filed 2024-03-26 | |||||||||||
| 2023-11-14 | $892.70M 10-K · filed 2026-04-15 | -$892.70M 10-K · filed 2024-03-26 | |||||||||||
| 2023-09-29 | $1.31B 10-Q · filed 2024-11-05 | $1.32B derived: sum of 2 quarters · filed 2024-11-05 | $1.32B 10-Q · filed 2024-11-05 | $1.28B derived: sum of 4 quarters · filed 2025-03-13 | |||||||||
| 2023-06-30 | $4.00M 10-Q · filed 2024-08-06 | $9.60M 10-Q · filed 2024-08-06 | -$31.30M derived: sum of 3 quarters · filed 2025-03-13 | -$13.60M derived: sum of 4 quarters · filed 2025-03-13 | |||||||||
| 2023-03-31 | $5.60M 10-Q · filed 2024-05-09 | -$35.30M derived: sum of 2 quarters · filed 2025-03-13 | -$17.60M derived: sum of 3 quarters · filed 2025-03-13 | ||||||||||
| 2022-12-30 | -$40.90M derived: 10-K 6 month − 10-Q 3 month · filed 2025-03-13 | -$23.20M 10-K · filed 2025-03-13 | |||||||||||
| 2022-09-30 | $14.20M 10-Q · filed 2023-11-07 | ||||||||||||
| 2022-07-01 | $3.50M 10-Q · filed 2023-08-09 | ||||||||||||
| 2022-06-16 | $587.50M 10-Q · filed 2023-08-09 | -$630.90M 10-K · filed 2025-03-13 | $630.90M 10-Q · filed 2022-08-11 | ||||||||||
| 2022-04-01 | $43.40M 10-Q · filed 2023-05-09 | -$714.00M derived: sum of 2 quarters · filed 2024-03-26 | -$587.80M derived: sum of 3 quarters · filed 2024-03-26 | -$478.30M derived: sum of 4 quarters · filed 2024-03-26 | |||||||||
| 2021-12-31 | -$757.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | -$631.20M derived: sum of 2 quarters · filed 2024-03-26 | -$521.70M derived: sum of 3 quarters · filed 2024-03-26 | -$428.20M 10-K · filed 2024-03-26 | $428.20M 10-K · filed 2022-03-15 | ||||||||
| 2021-09-24 | $126.20M 10-Q · filed 2022-11-08 | $235.70M derived: sum of 2 quarters · filed 2022-11-08 | $329.20M 10-Q · filed 2022-11-08 | $267.80M derived: sum of 4 quarters · filed 2023-03-03 | |||||||||
| 2021-06-25 | $109.50M 10-Q · filed 2022-08-11 | $203.00M 10-Q · filed 2022-08-11 | $141.60M derived: sum of 3 quarters · filed 2023-03-03 | $141.60M derived: sum of 4 quarters · filed 2023-03-03 | |||||||||
| 2021-03-26 | $93.50M 10-Q · filed 2022-05-03 | $32.10M derived: sum of 2 quarters · filed 2023-03-03 | $32.10M derived: sum of 3 quarters · filed 2023-03-03 | $32.10M derived: sum of 4 quarters · filed 2023-03-03 | |||||||||
| 2020-12-25 | -$61.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | -$61.40M derived: sum of 2 quarters · filed 2023-03-03 | -$61.40M derived: sum of 3 quarters · filed 2023-03-03 | -$61.40M 10-K · filed 2023-03-03 | $61.40M 10-K · filed 2021-03-10 | ||||||||
| 2020-09-25 | $0.00 10-Q · filed 2021-11-02 | $0.00 derived: sum of 2 quarters · filed 2021-11-02 | $0.00 10-Q · filed 2021-11-02 | ||||||||||
| 2020-06-26 | $0.00 10-Q · filed 2021-08-03 | $0.00 10-Q · filed 2021-08-03 | |||||||||||
| 2020-03-27 | $0.00 10-Q · filed 2021-05-04 | ||||||||||||
| 2019-12-27 | $0.00 10-K · filed 2022-03-15 | ||||||||||||
| 2018-12-28 | $0.00 10-K · filed 2021-03-10 |